208 related articles for article (PubMed ID: 28205056)
21. Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
Borer JS; Deedwania PC; Kim JB; Böhm M
Am J Cardiol; 2016 Dec; 118(12):1948-1953. PubMed ID: 27780557
[TBL] [Abstract][Full Text] [Related]
22. Effects of ivabradine therapy on heart failure biomarkers.
Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
[TBL] [Abstract][Full Text] [Related]
23. Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial).
Böhm M; Robertson M; Ford I; Borer JS; Komajda M; Kindermann I; Maack C; Lainscak M; Swedberg K; Tavazzi L
Am J Cardiol; 2015 Dec; 116(12):1890-7. PubMed ID: 26508709
[TBL] [Abstract][Full Text] [Related]
24. Assessment of health-related quality of life in a greek symptomatic population with atrial fibrillation: correlation with functional status and echocardiographic indices.
Tsounis D; Ioannidis A; Bouras G; Raikou M; Giannopoulos G; Deftereos S; Kossyvakis C; Toutouzas K; Tousoulis D; Synetos A; Pyrgakis V; Niakas D; Stefanadis C
Hellenic J Cardiol; 2014; 55(6):475-85. PubMed ID: 25432199
[TBL] [Abstract][Full Text] [Related]
25. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
[TBL] [Abstract][Full Text] [Related]
26. Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris.
Borer JS; Swedberg K; Komajda M; Ford I; Tavazzi L; Böhm M; Depre C; Wu Y; Maya J; Dominjon F
Cardiology; 2017; 136(2):138-144. PubMed ID: 27614723
[TBL] [Abstract][Full Text] [Related]
27. Characterizing patients with chronic heart failure in community care after hospitalization: a potential role for ivabradine.
Elder DH; Mohan M; Cochrane L; Charles H; Lang CC
Cardiovasc Ther; 2015 Jun; 33(3):104-8. PubMed ID: 25809454
[TBL] [Abstract][Full Text] [Related]
28. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
[TBL] [Abstract][Full Text] [Related]
29. Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study.
Borer JS; Böhm M; Ford I; Komajda M; Tavazzi L; Sendon JL; Alings M; Lopez-de-Sa E; Swedberg K;
Eur Heart J; 2012 Nov; 33(22):2813-20. PubMed ID: 22927555
[TBL] [Abstract][Full Text] [Related]
30. [Cost-effectiveness and budget impact of ivabradine in heart failure therapy].
Polistena B; Maggioni AP; Oliva F; Spandonaro F
G Ital Cardiol (Rome); 2014 Nov; 15(11):626-33. PubMed ID: 25424141
[TBL] [Abstract][Full Text] [Related]
31. Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials.
Fox K; Komajda M; Ford I; Robertson M; Böhm M; Borer JS; Steg PG; Tavazzi L; Tendera M; Ferrari R; Swedberg K
Eur Heart J; 2013 Aug; 34(29):2263-70. PubMed ID: 23536611
[TBL] [Abstract][Full Text] [Related]
32. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
[TBL] [Abstract][Full Text] [Related]
33. [Assessment of health-related quality of life in psoriasis patients in Hungary].
Poór AK; Sárdy M; Cserni T; Brodszky V; Holló P; Gulácsi L; Remenyik É; Szegedi A; Rencz F; Péntek M
Orv Hetil; 2018 May; 159(21):837-846. PubMed ID: 29779387
[TBL] [Abstract][Full Text] [Related]
34. Association between "loco-check" and EuroQol, a comprehensive instrument for assessing health-related quality of life: a study of the Japanese general population.
Iizuka Y; Iizuka H; Mieda T; Tajika T; Yamamoto A; Takagishi K
J Orthop Sci; 2014 Sep; 19(5):786-91. PubMed ID: 25023927
[TBL] [Abstract][Full Text] [Related]
35. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.
Swedberg K; Komajda M; Böhm M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
Lancet; 2010 Sep; 376(9744):875-85. PubMed ID: 20801500
[TBL] [Abstract][Full Text] [Related]
36. Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT).
Swedberg K; Komajda M; Böhm M; Borer JS; Ford I; Tavazzi L
Eur J Heart Fail; 2010 Jan; 12(1):75-81. PubMed ID: 19892778
[TBL] [Abstract][Full Text] [Related]
37. Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure.
Cosiano MF; Vista A; Sun JL; Alhanti B; Harrington J; Butler J; Starling RC; Mentz RJ; Greene SJ
Circ Heart Fail; 2023 Jan; 16(1):e010107. PubMed ID: 36314126
[TBL] [Abstract][Full Text] [Related]
38. Quantifying patient centered outcomes associated with the use of bilateral endobronchial coil treatment in patients with severe emphysema.
Evans R; Brutsche M; Busca R; Deslee G; de Soyza A; Fellrath JM; Franzen D; Hartman J; Mealing S; Morton T; Munavvar M; Sculpher M; Shah P; Slebos DJ; Durand-Zaleski I
Curr Med Res Opin; 2018 Nov; 34(11):1927-1932. PubMed ID: 29625529
[TBL] [Abstract][Full Text] [Related]
39. Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.
Ekman I; Chassany O; Komajda M; Böhm M; Borer JS; Ford I; Tavazzi L; Swedberg K
Eur Heart J; 2011 Oct; 32(19):2395-404. PubMed ID: 21875859
[TBL] [Abstract][Full Text] [Related]
40. Analyzing Health-Related Quality of Life in the EVOLVE Trial: The Joint Impact of Treatment and Clinical Events.
Briggs AH; Parfrey PS; Khan N; Tseng S; Dehmel B; Kubo Y; Chertow GM; Belozeroff V
Med Decis Making; 2016 Nov; 36(8):965-72. PubMed ID: 26987347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
